Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Rheumatol Int. 2013 Jul 2;33(11):2789–2796. doi: 10.1007/s00296-013-2811-3

Table 3.

Brachial artery diameter results, pre- and post-treatment

Period Variable Omega-3 mean (SD) Placebo mean (SD) p valuea
Pre-treatment Baseline, cm 0.32 (0.06) 0.33 (0.06) 0.52
30 s, cm 0.34 (0.06) 0.35 (0.06) 0.58
30 s % change 6.53 (5.51) 6.33 (6.63) 0.88
60 s, cm 0.36 (0.06) 0.37 (0.06) 0.43
60 s % change 12.02 (6.00) 12.31 (7.23) 0.84
90 s, cm 0.36 (0.06) 0.37 (0.06) 0.50
90 s % change 12.30 (6.83) 11.94 (7.24) 0.82
Post-treatment Baseline, cm 0.32 (0.04) 0.33 (0.06) 0.38
30 s, cm 0.34 (0.05) 0.35 (0.06) 0.43
30 s % change 5.97 (6.10) 5.73 (6.54) 0.87
60 s, cm 0.35 (0.04) 0.36 (0.06) 0.32
60 s % change 9.59 (6.93) 9.52 (6.60) 0.97
90 s, cm 0.35 (0.04) 0.36 (0.06) 0.23
90 s % change 8.48 (8.63) 9.00 (7.82) 0.78
Pre–post differences Baseline, cm 0.00 (0.04) 0.00 (0.05) 0.99
30 s % change –0.60 (7.80) –0.89 (0.83) 0.87
60 s % change –2.36 (10.01) –2.73 (8.72) 0.86
90 s % change –3.96 (11.73) –2.76 (9.68) 0.62
a

Based on a two-sample t test